Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia?

Am J Gastroenterol. 2002 Oct;97(10):2686-7. doi: 10.1111/j.1572-0241.2002.06062.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Amoxicillin / administration & dosage
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Ulcer Agents / administration & dosage
  • Antigens, Bacterial*
  • Bacterial Proteins / analysis
  • Benzimidazoles / administration & dosage
  • Clarithromycin / administration & dosage
  • Drug Therapy, Combination
  • Dyspepsia / drug therapy*
  • Dyspepsia / microbiology
  • Helicobacter Infections / complications
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori* / drug effects
  • Helicobacter pylori* / genetics
  • Humans
  • Omeprazole / analogs & derivatives
  • Penicillins / administration & dosage
  • Peptic Ulcer / drug therapy*
  • Peptic Ulcer / microbiology
  • Rabeprazole
  • Tinidazole / administration & dosage*

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Antigens, Bacterial
  • Bacterial Proteins
  • Benzimidazoles
  • Penicillins
  • cagA protein, Helicobacter pylori
  • Tinidazole
  • Rabeprazole
  • Amoxicillin
  • Clarithromycin
  • Omeprazole